-
Generating and Characterizing LRRK2 Antibodies
… normal and Parkinson’s cellular function. MJFF is funding multiple groups to develop therapies against LRRK2 that, if … selection of one or several antibodies that perform well in multiple different methodologies, and these will then be …
-
PROGENI Family Study
… We have previously recruited over 800 families having multiple members diagnosed with PD. About 5% of these … In addition, we will also recruit control families having multiple members with PD, but who do not have a LRRK2 …
-
Toshiya Nishi, DVM
… During his career as a pharmacologist, Dr. Nishi has led multiple drug discovery programs in diverse therapeutic …
-
Ryan Schubert, MD
… the targets and triggers of neuroinflammatory diseases like multiple sclerosis and acute flaccid myelitis. Ryan is …
-
Mike Snape, PhD
… for neuroscience. To date, Dr. Snape has innovated and led multiple translational programs: developing AMO-02 …
-
Yo-El S. Ju, MD, MSCI
… Alzheimer’s disease and Lewy body disease. She directs multiple clinical and translational research programs, …